Radiance Med Spa

The question every serious franchise investor asks before writing a check — "Is this brand worth my capital, my time, and the next decade of my professional life?" — is exactly the question this analysis is designed to answer with precision. The medical aesthetics industry has quietly become one of the most recession-resilient, demographically bulletproof sectors in all of consumer services, and Radiance Med Spa has been building its franchise model inside that opportunity since its founding in Belleair Bluffs, Florida, with its flagship location opening in the spring of 2006. The company was founded and is led by CEO Stephanie Schlageter, a credentialed engineer whose academic background spans a master's degree in Biomedical Engineering from Northwestern University, a bachelor's degree in Mechanical Engineering from Tufts University, and additional business education from the University of South Florida and Stanford University — a profile that sets Radiance Med Spa apart from the aesthetician-turned-entrepreneur archetype common in the medspa category. Schlageter's prior career as a Research and Development Engineer for a medical device company directly informs the brand's commitment to treatment safety, technological currency, and clinical effectiveness, which are three dimensions that are non-negotiable in a medically supervised services environment. The company's primary operational and franchise headquarters is associated with Belleair Bluffs, Florida, with a Fort Lauderdale, Florida address listed in its franchise data. The brand describes itself as offering non-surgical aesthetic skincare procedures within a luxurious medical facility that carries a tranquil spa environment — a deliberate hybrid positioning that captures both the clinical credibility of a medical practice and the experiential premium of a destination spa. The franchise network has developed with a notable distinction: Radiance Med Spa is cited as the only medspa franchise that maintains 100% regulatory compliance across all 50 states, a structural advantage that eliminates one of the most significant legal landmines in the medically supervised services franchise category. The current franchise network comprises 5 total units including 2 franchised locations, with the Radiance Medspa Group having previously awarded over 85 locations domestically and reported a rapidly expanding international presence. Radiance Med Spa has also been named on the Inc. 5,000 list of America's Fastest Growing Companies for three consecutive years, a benchmark that signals sustained revenue growth at the corporate level and validates the brand's market momentum during a critical scaling phase.

The medical spa industry represents one of the most structurally compelling sectors available to franchise investors in 2025, with multiple independent research sources converging on a picture of explosive, sustained global growth. The global medical spa market was estimated at USD 21.21 billion in 2024 and is projected to reach USD 78.23 billion by 2033, representing a compound annual growth rate of 15.77% from 2025 through 2033 — a CAGR that vastly outpaces most consumer services categories including fitness, casual dining, and traditional personal care. A parallel research projection estimates the market growing from USD 39.1 billion in 2025 to USD 75.5 billion by 2035, while a third analysis places the market at USD 26.2 billion in 2026 and USD 47.17 billion by 2031 at a 12.48% CAGR. North America commanded the largest global revenue share at 40.68% in 2024, and the U.S. medical spa industry is specifically anticipated to register the fastest CAGR from 2025 to 2033 among all regional markets. The number of medical spas operating in the United States increased from 8,899 locations in 2022 to approximately 10,488 in 2023, representing year-over-year unit growth of roughly 18% — a figure that demonstrates both strong consumer demand and a competitive landscape that is still fragmented enough to reward early-mover branded franchise operators. The consumer trends fueling this growth are structural rather than cyclical: aging millennials now in their prime income-earning years are visiting medspas at what industry analysts describe as astonishing rates, individuals aged 35 to 54 account for half of all procedures performed industry-wide, and those 55 and older constitute approximately one-third of all clients. The adult consumer segment led the medical spa market with a 70.69% revenue share in 2024 and is projected to register the fastest CAGR going forward. Rising awareness of self-care and anti-aging services, growth in wellness tourism, and accelerating consumer demand for minimally invasive non-surgical cosmetic procedures across all demographics collectively create secular tailwinds that make the Radiance Med Spa franchise opportunity highly relevant to investors evaluating long-term category positioning.

The Radiance Med Spa franchise investment requires a total initial capital commitment ranging from $365,000 on the low end to $678,700 at the high end, based on the most current franchise data available. This investment range reflects the brand's positioning in upscale retail environments and the clinical infrastructure required to operate a medically supervised aesthetics facility — factors that drive build-out costs higher than typical personal care service franchises but also create a physical and experiential barrier to entry that independent medspa operators struggle to replicate cost-effectively. The Radiance Medspa Group's franchise disclosure documents have cited an initial franchise fee of $80,000, which is positioned at the premium end of the personal care services franchise category and reflects the brand's clinical compliance architecture, multi-phase training certification program, and the regulatory scaffolding required to maintain 100% statutory compliance across all 50 states. The ongoing royalty fee is structured at 4% of revenues, which compares favorably against the broader franchise universe where royalty rates across personal care and wellness concepts frequently range from 5% to 8% of gross sales. Radiance Med Spa offers financing to qualified franchise candidates, which expands the accessible investor pool beyond those with full liquidity, and the brand provides a 10% discount on franchise fees for veterans, a meaningful incentive given the operational discipline and leadership profile that military-background candidates typically bring to franchise operations. The company has previously specified a minimum liquid capital requirement of $80,000 for franchise applicants, establishing a clear accessibility floor for the investment. When contextualizing the $365,000 to $678,700 total investment range against the medical spa industry's projected trajectory from $21.21 billion in 2024 to $78.23 billion by 2033, the capital at risk represents a calculated entry point into a category demonstrating some of the highest sustained growth rates in the entire consumer services franchise landscape. The spread between the investment floor and ceiling is primarily driven by real estate market variation, local build-out costs, and equipment configuration — variables that Radiance Med Spa's corporate team actively helps franchisees navigate through its established vendor relationships and architectural design support.

The Radiance Med Spa operating model is engineered for both physicians entering the franchise space and entrepreneurs without a medical background, making it one of the few medically supervised franchise concepts that does not require clinical licensure from its franchisees. Each location is designed for an upscale retail footprint of approximately 1,500 to 2,500 square feet, which positions the concept for high-visibility shopping center and lifestyle retail environments where the target demographic — adults aged 35 to 54 with disposable income and an existing orientation toward wellness — is already present and transacting. Radiance Med Spa deploys a comprehensive multi-phase certified training program that guides franchisees through all aspects of business operations, covering clinical protocols, regulatory compliance, staff management, marketing execution, and client experience standards. The support infrastructure goes beyond initial training: franchisees receive a full turnkey development program with continued ongoing assistance from experienced corporate staff throughout both the development phase and daily operations, along with a dedicated 1-800 customer service and support line that provides franchisees and their teams with direct access to brand expertise. Corporate support extends to site selection assistance conducted in collaboration with national commercial real estate firms, evaluating sites against demographic data, traffic counts, real estate costs, competitive density, parking availability, and signage visibility — a disciplined real estate process that directly influences the long-term revenue potential of each location. Franchisees also receive support in medical staff recruitment, operational systems implementation, ongoing marketing and advertising planning, and access to superior vendor contracts and warranties that independent operators cannot access at equivalent pricing. The brand's 100% compliance architecture across all 50 states is not merely a marketing claim — it is a structural operational advantage that means franchisees enter markets with a legally vetted operating framework already in place, eliminating the attorney fees and regulatory uncertainty that frequently derail independent medspa launches.

Item 19 financial performance data is not disclosed in the current Franchise Disclosure Document for Radiance Med Spa, which means that average unit revenue, median revenue figures, and profit margin ranges are not available through the FDD. This is a material consideration for investors conducting due diligence, as Item 19 financial performance representations are the primary mechanism through which franchisors provide prospective franchisees with empirical, audited data on what existing locations actually generate. When financial performance is not disclosed, investors must build their revenue models using industry benchmarks, unit count trajectory analysis, and comparable brand data. The global medical spa market's North American segment, which commands 40.68% of global revenue against a market base of $21.21 billion in 2024, implies a North American market approaching $8.6 billion, distributed across approximately 10,488 U.S. locations as of 2023 — producing a theoretical average revenue per location of approximately $820,000 per year at the industry mean. Top-performing medical spa locations in branded franchise environments routinely exceed $1 million to $2 million in annual revenue, particularly in high-income suburban markets that match the Radiance Med Spa site selection profile. The brand's own history is instructive here: Stephanie Schlageter navigated Radiance through a prior franchisor's failure — one characterized by overestimated revenue projections and underestimated startup costs and working capital requirements — and rebuilt the organization to profitability on a foundation of operational rigor. That institutional experience with the gap between projected and actual unit economics gives the current leadership team a rare, battle-tested perspective on what realistic franchise financial planning looks like in this category. Prospective franchisees are strongly advised to speak directly with existing Radiance Med Spa franchise owners, request audited financial summaries from the corporate team, and engage an independent franchise attorney and accountant before committing capital, regardless of whether Item 19 data is eventually made available.

The Radiance Med Spa franchise growth trajectory reflects a brand that has moved through multiple distinct phases since its 2006 founding. The organization was named to the Inc. 5,000 list of America's Fastest Growing Companies for three consecutive years, a metric that requires sustained revenue growth rates that place a company in the top 20% of all private U.S. companies — a significant marker of business velocity. The Radiance Medspa Group has cited over 85 locations awarded domestically with a rapidly expanding international presence, while more recent data from October 2021 records 30 franchise units in operation, and the current franchise database reflects 5 total units with 2 franchised locations — a unit count profile that may reflect the most actively operating and verified locations in the current network configuration. The brand's competitive moat is constructed on several reinforcing dimensions: Schlageter's biomedical engineering and medical device R&D background creates an institutionalized capability for evaluating and integrating emerging treatment technologies before competitors identify and adopt them; the 100% 50-state compliance architecture creates a legal and regulatory barrier to imitation that generic medspa operators cannot easily replicate; and the brand's physician-plus-entrepreneur franchisee model expands its addressable franchisee pool while maintaining clinical standards through corporate operational systems. The medspa category itself remains highly fragmented — the U.S. grew from 8,899 to 10,488 locations in a single year, the majority of which are independent owner-operated practices with limited brand equity, no franchise infrastructure, and no corporate compliance support. Radiance Med Spa's branded franchise model, combined with its medically supervised treatment philosophy, positions it as a consolidator of consumer trust in a category where trust and clinical credibility are the primary conversion drivers. The brand's emphasis on innovative technologies and medically supervised protocols directly addresses the consumer trend toward non-surgical, minimally invasive procedures that is driving the market's projected 15.77% CAGR through 2033.

The ideal Radiance Med Spa franchisee does not require a clinical or medical background — the brand explicitly opens its opportunity to both licensed physicians and entrepreneurs from entirely different professional disciplines, provided they genuinely understand and align with the brand's mission, values, and commitment to clinical excellence. Candidates with management experience, customer service orientation, and comfort in high-touch, premium-service environments are well-positioned for the operating model, given that the clinical protocols and regulatory compliance infrastructure are provided by the corporate framework rather than derived from the franchisee's personal medical training. Medical staff recruitment is handled with direct corporate support, which means franchisees operate as business leaders overseeing a clinical team rather than as individual practitioners. The concept's 1,500 to 2,500 square foot upscale retail footprint is most effectively deployed in affluent suburban markets with demographics skewing toward the 35-to-54 age cohort that accounts for half of all medspa procedures nationally. Multi-unit development is a natural extension of the model for qualified operators who want to build a portfolio within a defined geographic territory, given the site selection infrastructure and turnkey development program that reduce the complexity of successive location launches. The franchise agreement structure and territory exclusivity parameters are available through the current Franchise Disclosure Document, which prospective franchisees are legally entitled to receive at least 14 days before signing any agreement or making any payment.

The Radiance Med Spa franchise opportunity sits at the intersection of three powerful macro forces: a medical spa market projected to grow from $21.21 billion in 2024 to $78.23 billion by 2033 at a 15.77% CAGR, a fragmented competitive landscape where 10,488 mostly independent U.S. locations create a wide-open runway for branded franchise operators with compliance infrastructure, and a demographic wave of aging millennials and mid-life consumers driving medspa visit frequency to record levels. The brand's engineering-grounded leadership, its distinction as the only medspa franchise claiming 100% compliance across all 50 states, its three consecutive Inc. 5,000 appearances, and its total investment range of $365,000 to $678,700 with a 4% royalty rate together create a due diligence profile that warrants serious, structured evaluation by investors with interest in the premium personal care and aesthetics category. The absence of Item 19 financial performance disclosure in the current FDD is a meaningful variable that experienced franchise investors will weigh carefully, and independent financial validation through existing franchisee conversations and third-party benchmarking is essential before any capital commitment. PeerSense provides exclusive due diligence data including SBA lending history, FPI score breakdowns, location maps with Google ratings, FDD financial data across disclosure cycles, and side-by-side comparison tools that allow investors to benchmark Radiance Med Spa against comparable concepts across total investment, royalty structure, unit count trajectory, and franchisee satisfaction indicators. Explore the complete Radiance Med Spa franchise profile on PeerSense to access the full suite of independent franchise intelligence data.